Matthew Ronsheim

Insider Reports History

Location
Waltham, MA
Signature
/s/ Matthew Ronsheim
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Ronsheim:

Company Role Class Num Shares Value Price $ Report Date Ownership
Innoviva, Inc. Officer Common Stock 40,510 $653,426 $16.13 20 May 2024 Direct
Innoviva, Inc. Officer Non-statutory Stock Option 120,438 05 Mar 2024 Direct
Innoviva, Inc. Officer Nonqualified Stock Option 93,100 18 Jan 2024 Direct
Entasis Therapeutics Holdings Inc. Chief of Pharma Sciences & MFG Common Stock 0 $2.20 11 Jul 2022 Direct
Entasis Therapeutics Holdings Inc. Chief of Pharma Sciences & MFG Stock Option (right to buy) 0 11 Jul 2022 Direct

Insider Reports Filed by Matthew Ronsheim

Symbol Company Period Transactions Value $ Form Type Role Filing Time
INVA Innoviva, Inc. 20 May 2024 1 -$4,323 4 Officer 21 May 2024, 20:15
INVA Innoviva, Inc. 05 Mar 2024 2 +$189,988 4 Officer 07 Mar 2024, 19:02
INVA Innoviva, Inc. 20 Feb 2024 1 -$12,751 4 Officer 22 Feb 2024, 21:31
INVA Innoviva, Inc. 18 Jan 2024 2 -$25,680 4 Officer 22 Jan 2024, 21:16
INVA Innoviva, Inc. 01 Jan 2024 0 $0 3 Officer 10 Jan 2024, 20:26
/report/000110465922078801-ronsheim-matthew-2022-07-07 Entasis Therapeutics Holdings Inc. 07 Jul 2022 6 -$38,658 4 Chief of Pharma Sciences & MFG 11 Jul 2022, 16:09
/report/000110465922005425-ronsheim-matthew-2022-01-18 Entasis Therapeutics Holdings Inc. 18 Jan 2022 1 $0 4 Chief of Pharmaceutical Sciences and Manufacturing 19 Jan 2022, 15:04
/report/000110465921133635-ronsheim-matthew-2021-11-02 Entasis Therapeutics Holdings Inc. 02 Nov 2021 1 -$10,787 4 Chief, Pharma Sciences & MFG. 03 Nov 2021, 16:05
/report/000110465921128054-ronsheim-matthew-2021-10-19 Entasis Therapeutics Holdings Inc. 19 Oct 2021 2 -$11,991 4 Chief of Pharmaceutical Sciences and Manufacturing 20 Oct 2021, 16:05
/report/000110465922023783-ronsheim-matthew-2021-07-16 Entasis Therapeutics Holdings Inc. 16 Jul 2021 2 $0 4 Chief of Pharmaceutical Sciences and Manufacturing 15 Feb 2022, 15:04